BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23903049)

  • 1. How I treat heterozygous hereditary antithrombin deficiency in pregnancy.
    Bramham K; Retter A; Robinson SE; Mitchell M; Moore GW; Hunt BJ
    Thromb Haemost; 2013 Sep; 110(3):550-9. PubMed ID: 23903049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary antithrombin deficiency and pregnancy--what is the effective thromboprophylaxis?].
    Majak P; Vikskjold F; Abildgaard U
    Tidsskr Nor Laegeforen; 2003 Jan; 123(2):144-6. PubMed ID: 12607492
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol.
    Morikawa M; Ieko M; Nakagawa-Akabane K; Umazume T; Chiba K; Kawaguchi S; Mayama M; Saito Y; Watari H
    Int J Hematol; 2022 Jul; 116(1):60-70. PubMed ID: 35316497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
    Cox S; Eslick R; McLintock C
    J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial.
    Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA
    JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary antithrombin deficiency resulting in severe neonatal thrombosis].
    Niklassen US; Ingerslev J; Birkebaek NH
    Ugeskr Laeger; 2000 Nov; 162(45):6081-2. PubMed ID: 11107947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary antithrombin deficiency and pregnancy. Pregnancy course in six women with known hereditary antithrombin deficiency].
    Mohapeloa HL; Wellnitz H; Laursen B
    Ugeskr Laeger; 1998 Nov; 160(49):7130-4. PubMed ID: 9850619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-associated thrombosis.
    Pabinger I; Grafenhofer H
    Wien Klin Wochenschr; 2003 Aug; 115(13-14):482-4. PubMed ID: 13677267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Antithrombin Deficiency Presenting with Deep Venous Thrombosis During the Second Pregnancy.
    Yamashita M; Komaki T; Tashiro K; Inada Y; Iwata A; Ogawa M; Morishita E; Miura SI
    Intern Med; 2020 Jan; 59(2):235-239. PubMed ID: 31554754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency.
    Rogenhofer N; Bohlmann MK; Beuter-Winkler P; Würfel W; Rank A; Thaler CJ; Toth B
    Ann Hematol; 2014 Mar; 93(3):385-92. PubMed ID: 23999648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin.
    Macklon NS; Greer IA; Reid AW; Walker ID
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):672-5. PubMed ID: 8562839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.
    McLintock C; McCowan LM; North RA
    BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful administration of recombinant human antithrombin in a pregnant Japanese woman with hereditary antithrombin deficiency.
    Fujibe Y; Mariya T; Mizuuchi M; Ishioka S; Yoshida M; Saito T
    Taiwan J Obstet Gynecol; 2019 Nov; 58(6):849-851. PubMed ID: 31759540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary antithrombin deficiency in pregnancy - severe thrombophilic disorder as a danger for mother and foetus.
    Čápová Irena; Salaj Peter; Hrachovinová Ingrid
    Ceska Gynekol; 2021; 86(3):175-182. PubMed ID: 34167310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
    Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
    Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxis.
    Fox NS; Laughon SK; Bender SD; Saltzman DH; Rebarber A
    Obstet Gynecol; 2008 Oct; 112(4):884-9. PubMed ID: 18827132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
    Brandt P
    Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
    Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
    Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy.
    Ellison J; Walker ID; Greer IA
    BJOG; 2000 Sep; 107(9):1116-21. PubMed ID: 11002955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.